Biomarin Pharmaceutical Inc. · NASDAQ:BMRN
Viking Global Investors LP's stake in Biomarin Pharmaceutical Inc. fell to 4.30% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Viking Global Investors LP's stake in Biomarin Pharmaceutical Inc. fell to 4.30%, 8,322,179 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 4.30%
- Shares
- 8,322,179
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 13 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| VIKING GLOBAL INVESTORS LP | 4.30% | 8,322,179 |
| VIKING GLOBAL PERFORMANCE LLC | 2.80% | 5,397,003 |
| Viking Global Equities II LP | 0.10% | 107,937 |
| Viking Global Equities Master Ltd. | 2.80% | 5,289,066 |
| Viking Long Fund GP LLC | 1.10% | 2,094,037 |
| Viking Long Fund Master Ltd. | 1.10% | 2,094,037 |
| Viking Global Opportunities Parent GP LLC | 0.40% | 831,139 |
| Viking Global Opportunities GP LLC | 0.40% | 831,139 |
| Viking Global Opportunities Portfolio GP LLC | 0.40% | 831,139 |
| Viking Global Opportunities Liquid Portfolio Sub-Master LP | 0.40% | 831,139 |
| HALVORSEN OLE ANDREAS | 4.30% | 8,322,179 |
| Ott David C. | 4.30% | 8,322,179 |
| Shabet Rose Sharon | 4.30% | 8,322,179 |
Source
Related
- Biomarin Pharmaceutical Inc.
- Viking Global Investors LP
- Biomarin Pharmaceutical Inc. shareholders
- Schedule 13G/A · Viking Global Investors LP · Aug 14, 2025
- Form 4 · Friberg Gregory R · Oct 1, 2026
- Form 4 · Plenge Robert M · Sep 14, 2026
- Form 4 · Davis George Eric · Sep 3, 2026
- Form 4 · Countouriotis Athena · Jun 4, 2026
- Form 4 · Walbert Timothy P · Jun 4, 2026